Trial Profile
Proof of Principle Study of Pulse Dosing of IL-15 to Deplete the Reservoir in HIV Infected People on Optimized ART With Undetectable Plasma HIV RNA
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Inbakicept (Primary) ; Inbakicept (Primary)
- Indications HIV-1 infections
- Focus Adverse reactions
- 31 Jan 2022 According to an ImmunityBio media release, data from this study published in Nature Medicine.
- 31 Jan 2022 Results presented in the ImmunityBio Media Release.
- 24 Jan 2020 Status changed from active, no longer recruiting to completed.